The formulation uses its own Quantum Ayurveda technology to improve the energetic profile of the substance so that cells can take it in better As metabolic health remains a dominant…

The formulation uses its own Quantum Ayurveda technology to improve the energetic profile of the substance so that cells can take it in better

As metabolic health remains a dominant driver in the nutraceutical sector, berberine has emerged as a high-growth botanical, frequently categorised in consumer media as a natural GLP-1 alternative. But the industry has had a problem for a long time: low oral bioavailability. To reach therapeutic levels, traditional berberine supplementation usually needs high-frequency dosing (1,500mg/day), which can cause adverse effects in the GI tract and make it hard for patients to stick to their treatment plan.

Greenspace Herbs is addressing these pharmacokinetic limitations with Berberine QA. The formulation uses its own “Quantum Ayurveda” technology to improve the energetic profile of the substance so that cells can take it in better.

Berberine QA provides metabolic assistance at a much lower dose of 500mg per day by making molecules work better. This 66 per cent cut in the amount of berberine needed solves the main problems in the berberine market:

• Better gastric tolerance: Reducing the amount of unabsorbed alkaloids in the digestive tract helps with frequent GI problems.

• Better adherence: Switching from taking the medication three times a day to once a day makes patients much more likely to stick with it over the long term.

Shafiulla Hirehal Nuruddin, the founder and managing director of Greenspace Herbs, states, “We are focused on optimising the delivery mechanism of established botanicals.” “Our Quantum Ayurveda technology allows the body to utilise the compound more effectively, ensuring that the therapeutic benefits are achieved without the burden of high-dose regimens.”

The shift toward metabolic wellness—encompassing glycemic control, lipid management, and weight homeostasis—shows no signs of slowing. With the global berberine market projected to more than double over the next decade, the industry is moving away from “dosage wars” and toward sophisticated delivery science.